-
Global Biopharma Layoffs March 2026
Layoffs
Global Biopharma companies including Merck, Baye, and Novartis announce workforce reductions in March 2026 as part of cost-saving and strategic realignments, impacting research, technology, and leadership roles across their operations.
-
Merck Full Year 2025 Financial Report
Merck
Merck's 2025 performance shows 1% revenue growth, driven by strong sales of KEYTRUDA, new products like WINREVAIR, and growth in animal health. The company maintains cautious optimism for 2026 amid challenges like patent cliffs and currency fluctuations.
-
Global Biopharma Layoffs November 2025
Layoffs
This article tracks recent biotech and pharma layoffs, including major workforce cuts at Novo Nordisk, Takeda, GSK, Pharming, and others, as companies restructure operations, streamline pipelines, and refocus resources amid shifting market conditions.
-
-
-
Global Biopharma Layoffs July 2025
Layoffs
Biopharmaceutical industry sees major July layoffs, with companies like Sarepta, GSK, Century, and Sage Therapeutics cutting jobs amid restructurings, trial setbacks, and M&A activity.
-
-
-
-
靖西县|
上思县|
弋阳县|
桦甸市|
武强县|
巴中市|
仙居县|
米林县|
商城县|
玛多县|
荥阳市|
伊宁县|
蒙城县|
丹凤县|
金湖县|
柳江县|
苗栗市|
沭阳县|
潼南县|
博乐市|
康平县|
广水市|
山阳县|
浑源县|
台州市|
灌阳县|
大关县|
大埔区|
乌拉特中旗|
涞源县|
霍邱县|
惠安县|
商城县|
博爱县|
武宣县|
盈江县|
富平县|
岚皋县|
尉犁县|
兴海县|
卓尼县|